Amy Sion

730 total citations
8 papers, 238 citations indexed

About

Amy Sion is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Amy Sion has authored 8 papers receiving a total of 238 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Surgery and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Amy Sion's work include Cancer Immunotherapy and Biomarkers (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Colorectal and Anal Carcinomas (2 papers). Amy Sion is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Colorectal and Anal Carcinomas (2 papers). Amy Sion collaborates with scholars based in United States, Netherlands and Italy. Amy Sion's co-authors include Theodore Stewart Gourdin, Romano Danesi, William D. Figg, Tristan M. Sissung, Howard I. Scher, Paul L. Nguyen, Sean Sachdev, James A. Talcott, James L. Wade and R. Bryan Rumble and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Pharmaceutical Sciences and Seminars in Oncology.

In The Last Decade

Amy Sion

8 papers receiving 229 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy Sion United States	5	115	98	44	41	38	8	238
Alicja Puszkiel France	10	134 1.2×	50 0.5×	40 0.9×	34 0.8×	38 1.0×	29	304
Q. Zhang China	8	164 1.4×	110 1.1×	11 0.3×	34 0.8×	54 1.4×	27	272
F. Carabantes Spain	8	211 1.8×	62 0.6×	40 0.9×	72 1.8×	97 2.6×	27	347
Iurie Bulat United States	8	122 1.1×	93 0.9×	14 0.3×	30 0.7×	25 0.7×	23	203
Robert E. Fricke Germany	7	90 0.8×	128 1.3×	56 1.3×	40 1.0×	19 0.5×	16	287
Clark Williard United States	8	68 0.6×	69 0.7×	30 0.7×	44 1.1×	118 3.1×	11	270
Michael Palmer United States	8	164 1.4×	166 1.7×	13 0.3×	62 1.5×	20 0.5×	9	362
Anne‐Joy M. de Graan Netherlands	12	282 2.5×	80 0.8×	154 3.5×	28 0.7×	64 1.7×	16	425
Lynn Jongen Belgium	7	132 1.1×	47 0.5×	51 1.2×	99 2.4×	105 2.8×	13	237
Arthur Géraud France	9	150 1.3×	114 1.2×	20 0.5×	41 1.0×	7 0.2×	25	277

Countries citing papers authored by Amy Sion

Since Specialization

Citations

This map shows the geographic impact of Amy Sion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Sion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Sion more than expected).

Fields of papers citing papers by Amy Sion

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Sion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Sion. The network helps show where Amy Sion may publish in the future.

Co-authorship network of co-authors of Amy Sion

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Sion. A scholar is included among the top collaborators of Amy Sion based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Sion. Amy Sion is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Virgo, Katherine S., R. Bryan Rumble, Ronald de Wit, et al.. (2021). Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update. Journal of Clinical Oncology. 39(11). 1274–1305. 74 indexed citations

Gourdin, Theodore Stewart, Michelle M. Lilly, Arif Hussain, et al.. (2021). Preliminary results from a phase II trial of docetaxel before castration with degarelix in men with newly diagnosed metastatic prostate cancer.. Journal of Clinical Oncology. 39(6_suppl). 116–116. 2 indexed citations

Gourdin, Theodore Stewart, et al.. (2019). Cabozantinib use in metastatic renal cell carcinoma patients in clinical practice: Evaluation of dosing patterns, tolerability, and outcomes compared to clinical trials. Journal of Oncology Pharmacy Practice. 26(4). 861–865. 8 indexed citations

Sion, Amy, et al.. (2019). Evaluation of arthralgias in adult oncology patients receiving immune checkpoint inhibitors. Journal of Oncology Pharmacy Practice. 25(8). 1867–1872. 4 indexed citations

Gourdin, Theodore Stewart, et al.. (2018). Immune-related adverse events are linked with improved progression-free survival in patients receiving anti-PD-1/PD-L1 therapy. Seminars in Oncology. 45(3). 156–163. 58 indexed citations

Gourdin, Theodore Stewart, et al.. (2018). Association of immune related adverse events with improved progression-free survival in patients receiving anti-PD-1 / PD-L1 therapy irrespective of corticosteroid use.. Journal of Clinical Oncology. 36(15_suppl). e15088–e15088. 1 indexed citations

Sion, Amy, et al.. (2018). A pilot study to assess the pharmacy impact of implementing a chemotherapy-induced nausea or vomiting collaborative disease therapy management in the outpatient oncology clinics. Journal of Oncology Pharmacy Practice. 25(4). 847–854. 13 indexed citations

Sissung, Tristan M., et al.. (2007). CYP2D6 polymorphisms and the impact on tamoxifen therapy. Journal of Pharmaceutical Sciences. 96(9). 2224–2231. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact